1 Min Read
Dec 4 (Reuters) - Sanofi Sa:
* SANOFI’S TOUJEO® MET MAIN OBJECTIVE IN HEAD-TO-HEAD STUDY VERSUS INSULIN DEGLUDEC Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.